Wednesday, December 09, 2020 4:03:43 PM
Recent GLSI News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/01/2024 08:45:14 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/01/2024 08:15:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/01/2024 08:10:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 10:04:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:33:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 10:05:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 10:05:18 AM
- Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain • GlobeNewswire Inc. • 08/01/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 10:05:14 AM
- Greenwich LifeSciences Set to Join Russell 2000 Index Again • GlobeNewswire Inc. • 06/26/2024 11:33:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 10:20:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:10:09 AM
- Greenwich LifeSciences Announces $2.5 Million Private Placement • GlobeNewswire Inc. • 06/14/2024 10:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:30:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:30:42 PM
- Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe • GlobeNewswire Inc. • 03/12/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:05:19 AM
- Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators • GlobeNewswire Inc. • 02/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:05:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:15:41 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM